Mitsubishi Tanabe Pharma America, Inc.
$5.2M 3,683 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Olympus Corporation of the Americas
Olympus Corporation of the Americas reported $5,245,076.17 across General Payments, Research, and Ownership to 4,448 physicians and teaching hospitals across 4,476 transactions.
- $5.2M
- All-tracks total
- 4,476
- Transactions
- 4,448
- Recipients
- +$67.8K
- General Payments vs PY2023
Olympus Corporation of the Americas reported $5,245,076.17 across all CMS Open Payments tracks (General + Research + Ownership) to 4,448 physicians and teaching hospitals in Program Year 2024 - ranking #265 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,721,871.22, averaging $1.2K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer olympus-corporation-of-the-americas Olympus Corporation of the Americas
$5.2M · #265/1,925 · 0.0% industry · PY2024
- TOT $5.2M
- RANK #265
- SHARE 0.0%
- TXN 4,476
- RCP 4,448
- CAT 7
- GEN $4.7M
- ΔGEN +$67.8K
- TOP1 24.0%
- PY 2024
Volume peers
Nearest volume peer: Mitsubishi Tanabe Pharma America, Inc. ($5.2M)
Olympus Corporation of the Americas sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Olympus Corporation of the Americas's CMS-reported General Payments increased by $67.8K (+1.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: OLYMPUS CORPORATION OF THE AMERICASPY2023: OLYMPUS CORPORATION OF THE AMERICASPY2024: Olympus Corporation of the Americas. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,654,056.09
- PY2024
- $4,721,871.22
What the Data Shows for Olympus Corporation of the Americas
$5,245,076.17: that is what Olympus Corporation of the Americas reported in payments to 4,448 physicians and teaching hospitals during Program Year 2024, spread across 4,476 transactions ($1.2K per transaction, $1.2K per recipient). The company sits at rank #265 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 7 general-payment categories charted below, "Grant" is the largest at $2.9M across 64 transactions, 60.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 7 types of general payments, Olympus Corporation of the Americas's largest category was "Grant" at $2.9M - 60.4% of General Payments.
Olympus Corporation of the Americas reports 7 general-payment categories - the top three are Grant (60.4%), Education (20.8%), and Travel and Lodging (8.1%). The remaining 4 categories make up 10.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Olympus Corporation of the Americas divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Grant | $2.9M | 64 | 60.4% |
| Education | $981.4K | 491 | 20.8% |
| Travel and Lodging | $381.9K | 2,368 | 8.1% |
| Space Rental or Facility Fees | $312.9K | 22 | 6.6% |
| Consulting Fee | $145.0K | 117 | 3.1% |
| Food and Beverage | $48.0K | 1,369 | 1.0% |
| Charitable Contribution | $2.0K | 17 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,125,472.04 (45.0%) of $4,721,871.22 in this company's General Payments records across 501 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Olympus Corporation of the Americas
The five named recipients with the highest reported General Payments from this company
- 1
Adventhealth Orlando
$1,131,350.51 across 12 reported transactions
- 2
Mercy Medical Center
$282,178.41 across 6 reported transactions
- 3
U Of U Hospitals & Clinics
$269,635.08 across 5 reported transactions
- 4
Orlando Health
$242,731.11 across 4 reported transactions
- 5
Cedars-Sinai Medical Center
$199,576.93 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Olympus Corporation of the Americas's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Olympus Corporation of the Americas.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Olympus Corporation of the Americas.
Showing 6 of 1,924 companies with CMS-reported payment data.
SpringWorks Therapeutics, Inc.
$5.3M 4,420 recipients
Compare payment profiles
BioXcel Therapeutics, Inc.
$5.2M 532 recipients
Compare payment profiles
KLS-Martin L.P.
$5.3M 6,287 recipients
Compare payment profiles
Actelion Pharmaceuticals US, Inc.
$5.2M 31,311 recipients
Compare payment profiles
Intercept Pharmaceuticals, Inc.
$5.1M 13,236 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.